KELLY NORROD: Open Payments
NPI 1992946560 · LIVINGSTON, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$662 in 37 payments from 12 companies in 2025. Trend: 2023 $751 · 2024 $487 · 2025 $662
Food & beverage: $662
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $194 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $84 |
| Exact Sciences Corporation | 5 | $84 |
| GlaxoSmithKline, LLC. | 4 | $63 |
| Novo Nordisk Inc | 3 | $54 |
| ABBVIE INC. | 3 | $44 |
| Lilly USA, LLC | 2 | $33 |
| Phathom Pharmaceuticals, Inc. | 3 | $27 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $24 |
| PFIZER INC. | 1 | $19 |
Products named: CAPLYTA, Cologuard Collection Kit, BREZTRI, AIRSUPRA, TRELEGY ELLIPTA, FARXIGA, MOUNJARO, VRAYLAR.
Industry payments across TN — which companies pay providers there.
